PMID- 25274590 OWN - NLM STAT- MEDLINE DCOM- 20150105 LR - 20211021 IS - 1319-6138 (Print) IS - 1319-6138 (Electronic) IS - 1319-6138 (Linking) VI - 19 IP - 4 DP - 2014 Oct TI - Association between human leukocyte antigen-DR and demylinating Guillain-Barre syndrome. PG - 301-5 AB - OBJECTIVE: To find an association between human leukocyte antigen (HLA) class II DRB1, DRB3, DRB4, and DRB5 alleles frequencies in a sample of Iraqi patients with Guillain-Barre syndrome (GBS) and compare with a healthy control group. METHODS: We performed a cross-sectional study consisting of 30 Iraqi Arab patients with GBS attending the Neurological Department in the Neuroscience Hospital, Baghdad, Iraq between September 2012 and June 2013. The control group comprised 42 apparently healthy volunteers. Human leukocyte antigen genotyping for HLA DRB1, DRB3, DRB4, and DRB5 was performed using the polymerase chain reaction-sequence-specific primers method. The allele frequencies were compared across both groups. Major histocompatibility complex (MHC)-class II HLA-DR genotyping and serotyping were performed by software analysis. RESULTS: We found increased frequencies of HLA genotype DRB1*03:01 (p=0.0009), DRB1*07:01 (p=0.0015), and DRB4*01:01 (p<0.0001) in patients with GBS compared with healthy controls. The HLA DR6 was increased in the control group (p<0.0001). CONCLUSION: Our results suggest an association between HLA-DRB1*03:01, DRB1*07:01, DRB4*01:01, and HLA DR3, DR7 and a susceptibility to GBS. FAU - Hasan, Zaki N AU - Hasan ZN AD - HLA Typing Research Unit, Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq. FAU - Zalzala, Haider H AU - Zalzala HH FAU - Mohammedsalih, Hyam R AU - Mohammedsalih HR FAU - Mahdi, Batool M AU - Mahdi BM FAU - Abid, Laheeb A AU - Abid LA FAU - Shakir, Zena N AU - Shakir ZN FAU - Fadhel, Maithem J AU - Fadhel MJ LA - eng PT - Journal Article PL - Saudi Arabia TA - Neurosciences (Riyadh) JT - Neurosciences (Riyadh, Saudi Arabia) JID - 101252453 RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*03:01 antigen) RN - 0 (HLA-DRB4*01:01 antigen) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Alleles MH - Arabs/genetics MH - Child MH - Female MH - Gene Frequency MH - *Genes, MHC Class II MH - Genetic Predisposition to Disease MH - Guillain-Barre Syndrome/epidemiology/*genetics/immunology MH - HLA-DR Antigens/*analysis/genetics MH - HLA-DRB1 Chains/analysis/genetics MH - Histocompatibility Testing/methods MH - Humans MH - Iraq/epidemiology MH - Male MH - Middle Aged MH - Young Adult PMC - PMC4727669 EDAT- 2014/10/03 06:00 MHDA- 2015/01/06 06:00 PMCR- 2014/10/01 CRDT- 2014/10/03 06:00 PHST- 2014/10/03 06:00 [entrez] PHST- 2014/10/03 06:00 [pubmed] PHST- 2015/01/06 06:00 [medline] PHST- 2014/10/01 00:00 [pmc-release] AID - Neurosciences-19-301 [pii] PST - ppublish SO - Neurosciences (Riyadh). 2014 Oct;19(4):301-5.